don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Uromigos","authorlink":""},"src":"https:\/\/anchor.fm\/s\/13347ea8\/podcast\/play\/47910287\/https:\/\/d3ctxlq1ktw2nl.cloudfront.net\/staging\/2022-1-19\/9102bc01-31d2-f6eb-d051-f2a9fc2126ff.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202206\/9aed5f-417e-e2ab-039fa5_800.jpg"},"title":"Episode 158: ASCO GU 2022 PROpel Phase III olaparib and abiraterone in renal cancer","link":"javascript:;","id":"item-10064140"}]
